CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis
Silvia Park, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, Won Seog Kim, Seok Jin Kim
Cancer Research and Treatment. 2015;47(3):448-457.   Published online 2014 November 3    DOI: https://doi.org/10.4143/crt.2014.034

Excel Download

Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis
Cancer Research and Treatment. 2014;47(3):448-457   Crossref logo
Link1 Link2 Link3

Impact of Age Group on Febrile Neutropenia Risk Assessment and Management in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Regimens
Clinical Lymphoma Myeloma and Leukemia. 2012;12(5):297-305   Crossref logo
Link1 Link2

Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
Journal of Korean Medical Science. 2014;29(11):1493   Crossref logo
Link1 Link2 Link3

Detection of the Incidence of HBV, HCV Infection and Febrile Neutropenia Associated With CHOP With or Without Rituximab in Diffuse Large B-Cell Lymphoma–Treated Patients
Hospital Pharmacy. 2017;53(3):194-197   Crossref logo
Link1 Link2 Link3

Rituximab Plus CHOP is Superior to CHOP Alone for Aggressive Diffuse Large B-Cell Lymphoma: Interim Results of a GELA Phase III Trial
Clinical Lymphoma. 2001;1(4):257-258   Crossref logo
Link1 Link2

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP
Acta Haematologica. 2013;131(3):156-161   Crossref logo
Link1 Link2

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
International Journal of Hematology. 2009;90(1):74-80   Crossref logo
Link1 Link2 Link3 Link4

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP
Pathology & Oncology Research. 2010;17(2):243-247   Crossref logo
Link1 Link2 Link3

Carboplatin
Reactions Weekly. 2019;1780(1):93-93   Crossref logo
Link1 Link2 Link3

Correlation Analysis Between Hematological Toxicity and Body Composition in Patients With Diffuse Large B Cell Lymphoma Treated With CHOP±R Regimen
. 2020;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.